pharma · Neoplasms，Non-Small Cell Lung Cancer
Tianjin Hemay Pharmaceutical
Tianjin Hemay Pharmaceutical Co., Ltd
Tianjin Hemay Pharmaceutical clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Tianjin Hemay Pharmaceutical projects
1 ClinicalTrials.gov programs sponsored by Tianjin Hemay Pharmaceutical.
Tianjin Hemay Pharmaceutical has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Tianjin Hemay Pharmaceutical have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.